1. Home
  2. GFF vs CELC Comparison

GFF vs CELC Comparison

Compare GFF & CELC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Griffon Corporation

GFF

Griffon Corporation

HOLD

Current Price

$67.96

Market Cap

3.8B

Sector

Industrials

ML Signal

HOLD

Logo Celcuity Inc.

CELC

Celcuity Inc.

HOLD

Current Price

$103.89

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GFF
CELC
Founded
1959
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.1B
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
GFF
CELC
Price
$67.96
$103.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$101.50
$106.63
AVG Volume (30 Days)
275.9K
537.3K
Earning Date
05-07-2026
03-25-2026
Dividend Yield
1.26%
N/A
EPS Growth
N/A
N/A
EPS
1.41
N/A
Revenue
$2,519,926,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$49.46
N/A
Revenue Growth
N/A
N/A
52 Week Low
$63.92
$7.58
52 Week High
$97.58
$120.32

Technical Indicators

Market Signals
Indicator
GFF
CELC
Relative Strength Index (RSI) 24.38 40.10
Support Level $66.36 $103.65
Resistance Level $78.07 $117.27
Average True Range (ATR) 2.27 5.60
MACD -0.98 -0.71
Stochastic Oscillator 3.22 6.20

Price Performance

Historical Comparison
GFF
CELC

About GFF Griffon Corporation

Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products: is a provider of branded consumer and professional tools; residential, industrial and commercial fans; home storage and organization products; and Home and Building Products conducts its operations through Clopay Corporation (Clopay). Clopay is the manufacturer and marketer of garage doors and rolling steel doors in North America. The company generates a majority of its revenue from the Home and Building Products segment. Operates in USA, Europe, Canada, Australia, and Others.

About CELC Celcuity Inc.

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.

Share on Social Networks: